Drug Resistance among Pulmonary Tuberculosis Patients in Calabar, Nigeria

Akaninyene Otu,Lovett Lawson,Victor Umoh,Victor Ansa,Abdulrazak Habib,Soter Ameh

doi:10.1155/2013/235190

Akaninyene Otu, Lovett Lawson + Show 4 more

Open Access

https://doi.org/10.1155/2013/235190

Copy DOI

Abstract

Background. This study aimed to determine the pattern of drug susceptibility to first-line drugs among pulmonary TB patients in two hospitals in Calabar, Nigeria. Methods. This was a descriptive cross-sectional study carried out between February 2011 and April 2012. Sputum samples from consecutive TB patients in Calabar were subjected to culture on Lowenstein-Jensen (LJ) slopes followed by drug susceptibility testing (DST). The DST was performed on LJ medium by the proportion method. Results. Forty-two of the 100 Mycobacterium tuberculosis strains were found to be resistant to at least one drug. Resistance to only one drug (monoresistance) was found in 17 patients. No strains with monoresistance to rifampicin were found. Resistance to two drugs was found in 22 patients, while one patient was resistant to both three and four drugs. MDR TB was seen in 4% (4/100). The independent variables of HIV serology and sex were not significantly associated with resistance (P > 0.05). Conclusion. There was a high prevalence of anti-TB drug resistance in Calabar.

Highlights

Tuberculosis (TB), an ancient infectious disease caused by Mycobacterium tuberculosis, is the leading cause of death due to an infectious agent globally
TB and human immunodeficiency virus (HIV) coinfection and the exponential increase in drug resistance are greatly responsible for the resurgence of TB [3]
Most (96%) of the participants had received some form of education, and, majority (52%) were from the Efik tribe

Summary

Introduction

Tuberculosis (TB), an ancient infectious disease caused by Mycobacterium tuberculosis, is the leading cause of death due to an infectious agent globally. Drug-resistant TB is a case of TB (usually pulmonary) excreting bacilli resistant to one or more anti-TB drugs [5]. Acquired drug resistance results from exposure to a single drug due to irregular drug supply, inappropriate prescription, or poor adherence to treatment. This suppresses the growth of bacilli susceptible to that drug while permitting multiplication of drug-resistant organisms. This study aimed to determine the pattern of drug susceptibility to first-line drugs among pulmonary TB patients in two hospitals in Calabar, Nigeria. There was a high prevalence of anti-TB drug resistance in Calabar

Objectives

Results

Conclusion